OptiMag, 120 capsules
OptiMag is a proprietary blend of two of Albion®â€™s highly bioavailable, well-tolerated, patented, true amino acid chelates: Magnesium Glycinate/Lysinate and Di-Magnesium Malate (patent pending). This formula has been awarded with the Albion® Gold Medallion characterized by research-confirmed, highest bioavailability, outrivaling other preparations on the market.
Magnesium Glycinate/Lysinate has been subjected to a variety of clinical trials to determine its impact on clinical symptoms and physical performance, as well as its absorption, tolerability and safety. Among three bioavailability studies is a double-blind one that compared magnesium glycinate/lysinate to magnesium chloride. Eight blood samples drawn over 24 hours and urine specimens gathered four times within that same time period revealed the chelate was absorbed at a rate that was 228% higher than the chloride form; urinary excretion was lower from the chelate compared to the chloride. In this same study Albion®â€™s magnesium glycinate/lysinate was also better tolerated and produced a weaker laxative effect than the magnesium chloride.
In general, Albion® patented mineral chelates are resistant to competitive minerals, do not weaken the action of vitamins and pose a smaller risk of overdosing.
Di-Magnesium Malate, the other chelate in OptiMag 125â„¢, received its patent in 2004 (patent number 6,706,904) as dimetalhydroxymalate. Malic acid was chosen because just as in nature, it forms complexes with magnesium.
By weight, di-magnesium malate contains 69% malate. Each capsule of OptiMag 125â„¢ supplies 350 mg of malic acid. Magnesium and malate play critical roles in energy production under aerobic conditions or when oxygen is lacking.
Malic acid also appears to be able to chelate aluminum.
Magnesium, the second most abundant element in the body participates in about 300-350 enzymatic reactions in nearly all tissues. Deficiency is common and results from poor dietary intake, poor absorption and excessive losses through urine, stool, perspiration or lactation; certain drugs, certain herbs, kidney disease, excessive alcohol intake and/or drinking mostly â€œsoftâ€ water.
The mineralâ€™s roles in the clinical applications cited above are quite well established. Beyond commonly recognized clinical applications, researchers have demonstrated magnesium deficiency can cause subclinical inflammation in the small intestine producing significant functional changes there and in remote organs, as well as increased sensitivity to oxidative stress.
Children with magnesium intakes less than 75% RDA were 58% more likely to have elevated CRP.
Long term adequate magnesium intake has been shown to protect against gallstones in men. Adequate magnesium intake indeed has strong, farreaching health benefits.
All XYMOGEN® Formulas Meet or Exceed cGMP Quality Standards.